ALK+ lung cancer

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

ALK+ lung cancer
Mar 3, 2025, 15:33 | Blog
Balancing Cancer Treatment and Heart Health: Linamaria's Story - Oncogene Cancer Research
Oncogene Cancer Research shared a post on LinkedIn: "Did you know that some cancer drugs…
Feb 4, 2025, 14:41 | Blog
Estela Rodriguez: Coral Olazagasti discussed ALK+ lung cancer primary resistance to ALK TKIs
Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of the Thoracic Site Disease Group…
Dec 29, 2024, 10:14 | Insight
The quest for cancer cures is personal - ALK Positive
ALK Positive shared a post on X: “The quest for cancer cures is personal. Like…
Nov 28, 2024, 18:25 | Insight
Cathy, Vicki, and Leslie show the power of ALK+ lung cancer research
ALK Positive shared a post on X: “Cathy, Vicki, and Leslie show the power of…
Nov 8, 2024, 20:06 | Insight
For Amy research is about making memories with friends and family - ALK Positive
ALK Positive shared a post on X: “Amy from Perkasie, PA was diagnosed with ALK+…
Sep 6, 2024, 11:02 | Insight
Iván R. González: Advances in the treatment of advanced ALK+ lung cancer
Iván R. González, Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla, shared a post…
Sep 2, 2024, 17:09 | Insight
Genetic interactions that shape tumorigenesis
Vincent Lam, medical oncologist at Johns Hopkins Kimmel Cancer Center, shared a post by Monte…
Aug 12, 2024, 12:11 | Blog
Narjust Florez: What a honor to discuss young lung cancer and ALK + lung cancer with people of Latin America
Narjust Florez, Associative Director CCEP & Thoracic Oncologist at Dana-Farber News, shared a post on X:…
Jun 24, 2024, 02:19 | Blog
Narjust Florez: Discussing the management of ALK and lung cancer with NP McDonald
Narjust Florez shared on X:                     …
Jun 16, 2024, 17:20 | Insight
Yvonne Diaz: EU Medicines Agency has approved Alecensa (alectinib) for early stage stage ALK+ lung cancer
Yvonne Diaz, Co-founder of Oncogene Cancer Research, shared a post on X: “Great to see that…
All: 10 Posts: 1 - 100
Special Coverage